ATE291422T1 - Inierzierbare valnemulin formulierung - Google Patents

Inierzierbare valnemulin formulierung

Info

Publication number
ATE291422T1
ATE291422T1 AT00990671T AT00990671T ATE291422T1 AT E291422 T1 ATE291422 T1 AT E291422T1 AT 00990671 T AT00990671 T AT 00990671T AT 00990671 T AT00990671 T AT 00990671T AT E291422 T1 ATE291422 T1 AT E291422T1
Authority
AT
Austria
Prior art keywords
valnemulin
interminable
formulation
valnemulin formulation
interminable valnemulin
Prior art date
Application number
AT00990671T
Other languages
English (en)
Inventor
Kurt Koller
Franz Schwarz
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE291422T1 publication Critical patent/ATE291422T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT00990671T 1999-12-09 2000-12-07 Inierzierbare valnemulin formulierung ATE291422T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99811128 1999-12-09
PCT/EP2000/012346 WO2001041758A2 (en) 1999-12-09 2000-12-07 Valnemulin formulation

Publications (1)

Publication Number Publication Date
ATE291422T1 true ATE291422T1 (de) 2005-04-15

Family

ID=8243176

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00990671T ATE291422T1 (de) 1999-12-09 2000-12-07 Inierzierbare valnemulin formulierung

Country Status (19)

Country Link
US (1) US6284792B1 (de)
EP (1) EP1235566B1 (de)
JP (1) JP3864090B2 (de)
KR (1) KR100491464B1 (de)
CN (1) CN1188122C (de)
AR (1) AR029777A1 (de)
AT (1) ATE291422T1 (de)
AU (1) AU769857B2 (de)
BR (1) BR0016262B1 (de)
CA (1) CA2390047C (de)
DE (1) DE60018967T2 (de)
DK (1) DK1235566T3 (de)
ES (1) ES2240232T3 (de)
MX (1) MXPA02005705A (de)
PT (1) PT1235566E (de)
RU (1) RU2270676C2 (de)
TW (1) TWI228048B (de)
WO (1) WO2001041758A2 (de)
ZA (1) ZA200204460B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5390081A1 (es) * 2001-11-28 2004-04-30 Novartis Ag Compuestos organicos
US6918561B2 (en) * 2002-10-31 2005-07-19 Yon So Chong Shell assembly for winding tire cord strip or belt cord strip
CN101744799B (zh) * 2008-12-12 2012-01-11 北京大北农科技集团股份有限公司 一种兽用沃尼妙林及其盐的脂质体新剂型及其制备方法
CN101947203A (zh) * 2010-10-14 2011-01-19 郑州后羿制药有限公司 一种兽用盐酸沃尼妙林乳剂及其制备方法
CN103288694B (zh) * 2013-06-28 2015-06-17 宁夏泰瑞制药股份有限公司 一种截短侧耳素类合成衍生物盐的晶体制备方法
CN103483232B (zh) * 2013-09-25 2015-05-13 宁夏泰瑞制药股份有限公司 一种盐酸沃尼妙林的精制方法
CN103520099A (zh) * 2013-10-30 2014-01-22 王玉万 含有效成份为沃尼妙林的长效注射剂
CN103705454B (zh) * 2014-01-07 2016-08-31 王玉万 含盐酸沃尼妙林/泊洛沙姆407的油质注射剂
CN104689324A (zh) * 2014-07-30 2015-06-10 王玉万 含亲水性治疗药物可乳化油质注射剂的制备方法
CN104311464A (zh) * 2014-09-15 2015-01-28 河北威远动物药业有限公司 一种兽用沃尼妙林的制备方法
KR102098289B1 (ko) * 2018-04-11 2020-04-07 경북대학교 산학협력단 발네물린을 유효성분으로 함유하는 골 질환 예방 또는 치료용 조성물
CN108635333B (zh) * 2018-07-10 2021-10-01 四川通达动物保健科技有限公司 一种盐酸沃尼妙林冻干粉针剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3560511D1 (en) * 1984-02-17 1987-10-01 Sandoz Ag Pleuromutilin derivatives, process for their preparation and their use
HU208115B (en) * 1989-10-03 1993-08-30 Biochemie Gmbh New process for producting pleuromutilin derivatives
GB9614017D0 (en) * 1996-07-04 1996-09-04 Biochemie Gmbh Organic compounds

Also Published As

Publication number Publication date
WO2001041758A2 (en) 2001-06-14
US6284792B1 (en) 2001-09-04
KR100491464B1 (ko) 2005-05-25
ES2240232T3 (es) 2005-10-16
CN1188122C (zh) 2005-02-09
ZA200204460B (en) 2003-09-03
TWI228048B (en) 2005-02-21
EP1235566A2 (de) 2002-09-04
DE60018967T2 (de) 2006-03-23
KR20020064335A (ko) 2002-08-07
WO2001041758A3 (en) 2002-03-07
AR029777A1 (es) 2003-07-16
CN1409631A (zh) 2003-04-09
PT1235566E (pt) 2005-08-31
BR0016262A (pt) 2002-08-13
JP3864090B2 (ja) 2006-12-27
CA2390047C (en) 2010-03-16
EP1235566B1 (de) 2005-03-23
RU2270676C2 (ru) 2006-02-27
CA2390047A1 (en) 2001-06-14
DK1235566T3 (da) 2005-06-20
MXPA02005705A (es) 2002-09-18
JP2003516352A (ja) 2003-05-13
WO2001041758A8 (en) 2002-08-29
US20010021693A1 (en) 2001-09-13
AU769857B2 (en) 2004-02-05
AU3007701A (en) 2001-06-18
DE60018967D1 (de) 2005-04-28
BR0016262B1 (pt) 2014-10-21

Similar Documents

Publication Publication Date Title
NO2019016I1 (no) dasatinib
DE60114145D1 (de) Fulvestrant formulierung
ID28698A (id) Formulasi antiparasit
DE69916329D1 (de) Kosmetische formulierung
ID29635A (id) Formulasi mikrokapsul
NO992339L (no) Farmasöytiske formuleringer
DK1168916T3 (da) Landbrugskemikalieformuleringer
ATE259590T1 (de) Pour-on formulierungen
BR0012303B1 (pt) composição de gordura
PL364768A1 (pl) Analogi witaminy D
EE200200150A (et) Preparaat
IS6398A (is) Lyfjablöndur
ATE218675T1 (de) Befestigungsmittel
DK1058720T3 (da) Smøremiddelpræparat
DK1200399T3 (da) Vitamin D3-analoger
ID30454A (id) Turunan-turunan monofluorialkil
ID27655A (id) Formulasi mikrokapsul
DK1235824T3 (da) D-vitaminanaloge forbindelser
ATE291422T1 (de) Inierzierbare valnemulin formulierung
ID30032A (id) Formulasi farmasi
AR025867A1 (es) Formulacion portasdora farmaceutica
ATE321497T1 (de) Tibiamarknagel
DE50000235D1 (de) Halmteiler
SE9903391D0 (sv) Novel formulation
SE9902902D0 (sv) New formulation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1235566

Country of ref document: EP